State Street’s Aura Biosciences AURA Stock Holding History

State Street’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.45M	Buy	964,670 +38,136	+4%	+$219K	﹤0.01%	2832
2025 Q4	$5.05M	Buy	926,534 +47,663	+5%	+$283K	﹤0.01%	2989
2025 Q3	$5.43M	Buy	878,871 +22,685	+3%	+$148K	﹤0.01%	2972
2025 Q2	$5.36M	Buy	856,186 +63,175	+8%	+$369K	﹤0.01%	2913
2025 Q1	$4.65M	Sell	793,011 -8,812	-1%	-$66.7K	﹤0.01%	2906
2024 Q4	$6.59M	Buy	801,823 +47,020	+6%	+$443K	﹤0.01%	2836
2024 Q3	$6.73M	Buy	754,803 +26,841	+4%	+$230K	﹤0.01%	2817
2024 Q2	$5.5M	Buy	727,962 +158,158	+28%	+$1.16M	﹤0.01%	2888
2024 Q1	$4.47M	Buy	569,804 +63,542	+13%	+$527K	﹤0.01%	2972
2023 Q4	$4.49M	Buy	506,262 +48,902	+11%	+$414K	﹤0.01%	2998
2023 Q3	$4.1M	Buy	457,360 +4,093	+0.9%	+$44K	﹤0.01%	3019
2023 Q2	$5.6M	Buy	453,267 +104,712	+30%	+$1.12M	﹤0.01%	2941
2023 Q1	$3.23M	Buy	348,555 +37,865	+12%	+$393K	﹤0.01%	3150
2022 Q4	$3.26M	Buy	310,690 +12,252	+4%	+$156K	﹤0.01%	3226
2022 Q3	$5.41M	Buy	298,438 +41,692	+16%	+$631K	﹤0.01%	3020
2022 Q2	$3.64M	Buy	256,746 +171,764	+202%	+$2.84M	﹤0.01%	3252
2022 Q1	$1.87M	Buy	84,982 +37,797	+80%	+$720K	﹤0.01%	3596
2021 Q4	$801K	Buy	+47,185	New	+$843K	﹤0.01%	3865

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street's AURA Position: Q1 2026 in Review

State Street increased its Aura Biosciences (AURA) stake by 4.1% in Q1 2026, buying an estimated $219K and bringing the position to 964,670 shares worth $6.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2832.

State Street first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.73M in Q3 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

State Street held 964,670 shares of Aura Biosciences worth $6.45M as of Q1 2026.
State Street bought 38,136 Aura Biosciences shares in Q1 2026, an estimated $219K.
Aura Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2832 holding.
State Street first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
State Street's Aura Biosciences position peaked at $6.73M in Q3 2024.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.